Research & Development

R&D Projects

Research and development activities supporting innovation in therapeutic drug monitoring.

Since 2024 · Ongoing

Individualisation of busulfan dosing in children

Monitlab S.A. performs busulfan assays as part of the project: "Individualisation of busulfan dosing based on plasma drug concentration measurement in conditioning protocols prior to haematopoietic stem cell transplantation in children".

The project is being carried out by Prof. Krzysztof Kałwak MD PhD from the Department of Bone Marrow Transplantation, Oncology and Paediatric Haematology "Cape of Hope" at the University Clinical Hospital in Wrocław, under the National Grant Programme. Funded by the Foundation "For the Rescue of Children with Cancer" under the substantive patronage of the Polish Society of Paediatric Oncology and Haematology.

2020 – 2021 · Completed

HPLC method for posaconazole assay

R&D Project: Development of an HPLC method for determining posaconazole levels in human plasma for therapeutic drug monitoring to improve the safety of systemic fungal infection therapy in haemato-oncological patients.

Project funding

Total cost
1 000 000 PLN
Public funding (80%)(NCBR)
800 000 PLN
Private support (20%)(Polish Venture Fund)
200 000 PLN

Agreement under the Smart Growth Operational Programme 2014–2020 · Measure 1.3 · Sub-measure 1.3.1 · BRIdge Alpha · NCBR · 23.01.2020

Preparing laboratory samples using a pipette

Interested in research collaboration?

We are open to new projects and partnerships.

Let's talk